August 27, 2001
Issue


 

COVER
   

Villains Of The Economy
As the economic downturn worsens, the Vajpayee Government comes under fire for holding up key reforms. INDIA TODAY analyses the performance of 10 ministers to find the extent and causes of inefficiency.

 

 
THE NATION
   

The Shadow Of Fear
In a bid to regain the initiative after the Agra Summit, militants have moved to the Jammu region-stretching the security forces and sparking tension.

 

 
STATES
 

Crime And Reward
The Chautala Government indulges in a controversial spate of forgiveness, pardoning murder convicts, most of whom are close to ruling party politicians.

 

 
SCIENCE
 

New Pot Of Gold
While the US debates the ethics of a cutting-edge medical technique that uses cells from embryos, India can march ahead-if it gets its act together.

 

 
OTHER STORIES
     
 



 
  Home  
 

SCIENCE : STEM CELL RESEARCH

New Pot Of Gold

Indian bio-tech laboratories are well placed to cash in on the medical revolution expected from research on embryonic cells. But the funding so far has been half-hearted.

Much like Yves St Laurent and John Galliano, James Thompson and John Gearhart are designers of a rare breed. Their designs dare to push the edge of human imagination. Thompson and Gearhart are in the business of developing organs-a kidney here to match the missing one, heart cells to replace those withering under attack, pancreatic cells that ooze insulin for the diabetic, blood cells for leukaemia patients, even new bones. They promise a revolution that will transform the very concept of medical treatment.

Like all great designers, their work has inspired countless others, and sparked more than a whiff of controversy. The basic material for the research involves what are called stem cells drawn from embryos. The inherent ethics involved has stirred a passionate debate that has divided the US in the past month. And if Indians are smart, these reservations can open an opportunity to march ahead, both in business and science. Hard-nosed businessmen are as excited as scientists about the cells' potential. "The mind boggles," says Kiran Mazumdar Shaw, CEO of Biocon India, "you can grow organs in a lab, cure diseases, even do away with blood banks."

Already, Spanish researchers have successfully persuaded embryonic stem cells in mice to grow into insulin-producing cells. In the US, scientists from the National Institutes of Health have produced neurons that secret dopamine, a brain chemical the loss of which leads to Parkinson's disease. Recently, Gearhart's team used human embryonic stem cells to help paralysed mice move.

Less dramatic, but equally important, is the use of stem cells to test drugs. It is a use that may finally find approval with both pharmaceutical companies and animal rights activists. Today, drugs come to the market after prolonged tests on animals and people to check efficacy and harmful effects. Once stem cells are coaxed to specialise into the required tissue, testing in animals may no longer be necessary, making the process of drug development quicker, cheaper and more effective. Lower in the list of money-spinning applications is basic research into how an egg grows into a whole being, and where nature can slip, creating deformed babies. With stem cells one can study every step in detail under laboratory conditions which would be impossible inside a womb.

Yet, the anti-abortionists are seeing red. Coming on the heels of the controversy of human cloning, the move to harvest stem cells for research has generated much heat, especially in the US. The anti-abortionists feel it is wrong to use human life as a tool. But do stem cells constitute life? They are, after all, "blank" cells that have not yet grown into any discernible part of the human body, say scientists. Moreover, they are created in Petri dishes, not in the womb.

Others disagree. US President George Bush has limited federal funding for stem cell research and disallowed the use of freshly-created embryos for extracting stem cells. "We can't end some lives for the medical benefit of others," he says. So the research will be limited to cell lines already created-about 60. A stem cell line is a self-replenishing colony of cells farmed with great difficulty. Only a handful of countries, including India, have such cell lines.

DESIGNER CELLS
Embryo cells can be the key to medical breakthroughs

1. An egg cell is stripped of its nucleus and the nucleus of another cell from the body is inserted into the egg.

2. Several eggs are fertilised with sperms in the lab for infertile couples. Not all are used. The back-up eggs are used to extract stem cells. At present in vitro fertilisation is more commonly used for collecting stem cells.

3. After five or six days the egg divides itself into a group of 200-250 cells. The inner cell mass contains embryonic stem cells which have the ability to develop into any of the 220 cell types found in human beings.

4. Stem cells are cultured in a Petri dish in a nutrient-rich medium and sterile conditions.

5. When given the right biochemical signals, stem cells are coaxed to specialise, forming tissues like those of heart, liver, pancreas or brain.

WHY THE EXCITEMENT

# India has better access to embryos for extracting stem cells thanks to its large population.

# Widely prevalent diseases in India like diabetes and heart problems can be cured more effectively.

# India has the manpower and expertise to compete globally provided adequate funds are injected.

 


 
Search    



     METRO TODAY
 
   

MetroScape

Singers' Pact
The latest from the stable of cocky bratpacks is 20-year-old Ishita Arun, daughter of singer Ila Arun, who staged her theatrical debut with Goonj at Mumbai's Prithvi Theatre last week.
more...


Looking Glass

Delhi Exhibition:
Figures In My Mind

Delhi Night Club-Restaurant: Nyx

Mumbai Lifestyle Store: Yantra

 

 
    Web Exclusives
DESPATCHES
 

The male model is an unwanted species now. Nothing, not even their opouts, poses and exposes, is helping him turn the corner. An epitaph by INDIA TODAY's Himanshi Dhawan in
Preety Boys No More

 

 
PREVIOUS ISSUE




Click here to view
the previous issue

 

 

 

CONTACT US SUBSCRIPTION PRIVACY POLICY